Triglyceride-rich lipoproteins and glycoproteins potential biomarkers in the development of steatosis.
Recently, metabolically associated fatty liver disease (MAFLD) has become one of the leading causes of chronic liver disease worldwide, and
Discover the most recent news about our Company.
Recently, metabolically associated fatty liver disease (MAFLD) has become one of the leading causes of chronic liver disease worldwide, and
High plasma triglyceride (TG) levels and chronic inflammation are important factors related to metabolic-associated fatty liver disease in patients at
Abstract High plasma triglyceride (TG) levels and chronic inflammation are important factors related to metabolic-associated fatty liver disease in patients
El passat 24 de novembre va tenir lloc a Madrid el seminari Biotec “2021 l’any de la biotecnologia” en el
On 24 November, the Biotec seminar “2021 the year of biotechnology” took place in Madrid as part of the second
Patients with type 2 diabetes mellitus (T2DM) and atherogenic dyslipidemia (AD) are at higher risk of developing cardiovascular diseases (CVDs),
Last 23rd and 24th November, our Quality Manager Sara Samino, participated in the first Futurecamp Open Future, eHealth & Wellbeing
El passat 23 i 24 de novembre, la nostra Quality Manager Sara Samino, va participar al primer Futurecamp Open Future,
We aimed to assess the potential relationship between dietary patterns (i.e., Mediterranean diet and healthy eating) and the advanced lipoprotein
From 12 to 15 November took place the “The liver Meeting” organised by the American Association for the Study of
El Barça Innovation Hub (BIHUB) va néixer fa 4 anys creat pel club blaugrana per desenvolupar al nivell més alt
The Barça Innovation Hub (BIHUB) was created four years ago by the FC Barcelona to develop technological advances applied to sport